青少年与青年烧伤患者重建植皮供区脂质体布比卡因浸润的回顾性分析
回顾性分析30例14-25岁需至少两次重建植皮手术的烧伤患者,比较供区浸润脂质体布比卡因(44例次)与标准治疗盐酸布比卡因(53例次)的术后疼痛。脂质体布比卡因组术后0-4小时疼痛评分均值1.4/10 vs 2.3/10(p=0.04)、0-24小时1.7/10 vs 2.4/10(p=0.02),均降低且达统计学显著;两组均无不良事件,住院时长与住院期间术后阿片类药物用量差异未被视为显著。作者认为差异很可能无临床意义,需进一步评估。
要点
- 脂质体布比卡因组0-4小时疼痛评分均值1.4/10,标准治疗组2.3/10(p=0.04)
- 脂质体布比卡因组0-24小时疼痛评分均值1.7/10,标准治疗组2.4/10(p=0.02)
- 两组均无不良事件,住院时长及住院期间术后阿片类药物用量差异未被视为显著
核心结论
- 作者报告首次结果,提示术中脂质体布比卡因供区浸润可能与青少年与青年烧伤患者结局的统计学改善相关,但所报告的差异很可能无临床意义,需在该独特人群中进一步评估。
研究设计与样本
- 回顾性分析,纳入14-25岁、至少接受两次重建植皮手术(一次供区浸润标准治疗盐酸布比卡因、一次浸润脂质体布比卡因)的患者。
- 最终样本30例患者,共分析44例次脂质体布比卡因与53例次标准治疗。
主要发现
- 脂质体布比卡因组较标准治疗组术后0-4小时疼痛评分均值1.4/10 vs 2.3/10,p=0.04,差异有统计学意义。
- 脂质体布比卡因组较标准治疗组术后0-24小时疼痛评分均值1.7/10 vs 2.4/10,p=0.02,差异有统计学意义。
- 两种镇痛药均未伴随不良事件。
- 住院时长与住院期间术后阿片类药物用量的差异未被视为显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文为回顾性分析。
- 原文结论认为所报告的差异很可能无临床意义,并指出需在该独特患者人群中进一步评估脂质体布比卡因的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative pain at skin graft donor sites is frequently undertreated in burn patients, which can impair reconstructive outcomes and result in harmful psychological consequences. We find a critical need to explore and promote non-opioid, multimodal analgesics. Donor site infiltration of the local anesthetic liposomal bupivacaine in adolescent and young adult burn patients has not been previously investigated. Therefore, the goal of this study was to evaluate intraoperative liposomal bupivacaine infiltration for postoperative donor site pain control in adolescent and young adult burn patients undergoing reconstructive skin graft procedures. METHODS: This retrospective analysis included patients aged 14-25 years, who underwent at least two reconstructive skin graft procedures, one that received donor site infiltration of the standard treatment (bupivacaine hydrochloride) and one that received donor site infiltration of liposomal bupivacaine. The final sample included 30 patients with a total of 44 liposomal bupivacaine cases and 53 standard treatment cases analyzed. RESULTS: In the authors' five-year experience, the use of liposomal bupivacaine compared to standard treatment was associated with statistically significant decreases in 0-4 h postoperative pain scores (mean 1.4/10 versus 2.3/10, p = 0.04) and 0-24 h postoperative pain scores (mean 1.7/10 versus 2.4/10, p = 0.02). Neither analgesic was associated with adverse events. Differences in length of stay and inpatient postoperative opioid usage were not regarded as significant. CONCLUSION: In this retrospective analysis, the authors report the first results that suggest intraoperative liposomal bupivacaine donor site infiltration may be associated with statistically improved patient outcomes in adolescent and young adult burn patients. However, the reported differences are most likely not clinically significant, establishing the necessity for further evaluation of using liposomal bupivacaine in this unique patient population.
引用
- Sadeq F, DePamphilis MA, Dabek RJ, et al. Evaluation of liposomal bupivacaine infiltration at reconstructive skin graft donor sites in adolescent and young adult burn patients: A retrospective analysis. Burns. 2021. PMID: 34862091. doi:10.1016/j.burns.2021.08.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。